Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

PROCA1 – Intellectual Disability

PROCA1 (HGNC:28600) has recently emerged as a candidate gene in individuals with intellectual disability (MONDO_0001071). In a prospective genomic study of 337 subjects, PROCA1 was nominated alongside other genes bearing de novo and recessive variants (PMID:27431290). Although the precise number of unrelated probands with PROCA1 variants has not been delineated, its identification in both individual case reports and multi‑patient analyses supports a tentative gene‑disease association.

The inheritance pattern for PROCA1‐related intellectual disability appears to be autosomal recessive; however, detailed segregation analyses and variant‑level evidence remain limited. Furthermore, no functional assays or animal/cellular model studies have been reported to clarify its pathogenic mechanism. Key take‑home: Although preliminary genetic evidence suggests that PROCA1 may contribute to intellectual disability, additional comprehensive studies are needed to validate its clinical utility.

References

  • Molecular psychiatry • 2017 • Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield PMID:27431290

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

PROCA1 is reported as a candidate gene in genomic analyses of intellectual disability, but with minimal independent proband and segregation data (PMID:27431290).

Genetic Evidence

Limited

While PROCA1 variants have been identified in multi‑patient studies, the lack of detailed variant-level data and clear segregation limits the strength of genetic evidence.

Functional Evidence

Limited

No functional assays or experimental studies have been reported to elucidate the pathogenic mechanism for PROCA1.